Public Health Service (PHS) Agencies: Background and Funding

Public Health Service (PHS) Agencies: Background and Funding

ȱ
ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱ
ŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
Š–Ž•Šȱǯȱ–’?‘ǰȱ˜˜›?’—Š?˜›ȱ
—Š•¢œ?ȱ’—ȱ’˜–Ž?’ŒŠ•ȱ˜•’Œ¢ȱ
Š›Œ‘ȱŘŜǰȱŘŖŖŞȱ
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŝȬśŝŖŖȱ
   ǯŒ›œǯ?˜Ÿȱ
řŚŖşŞȱ
ȱŽ™˜›?ȱ?˜›ȱ˜—?›Žœœ
Pr
epared for Members and Committees of Congress

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
ž––Š›¢ȱ
The U.S. Public Health Service (PHS) originated in an act of July 16, 1798, that authorized
marine hospitals for the care of American merchant seamen. Over the years, the scope and
responsibilities of the act and the service have broadened. The Public Health Service Act of July
1, 1944, revised and consolidated into one law all legislation existing at that time relating to
programs and activities of the PHS. The act, codified at 42 U.S.C. § 201 et seq., has been
amended and extended nearly every year since 1944 and currently includes 29 titles.
The PHS Act is administered by the Department of Health and Human Services (HHS) through
eight operating agencies. Those agencies are
• the Agency for Healthcare Research and Quality (AHRQ),
• the Agency for Toxic Substances and Disease Registry (ATSDR),
• the Centers for Disease Control and Prevention (CDC),
• the Food and Drug Administration (FDA),
• the Health Resources and Services Administration (HRSA),
• the Indian Health Service (IHS),
• the National Institutes of Health (NIH), and
• the Substance Abuse and Mental Health Services Administration (SAMHSA).
The Agency for Toxic Substances and Disease Registry is administered by the Director of the
CDC, and the two agencies are discussed together in this report. Together, the PHS agencies
administer more than 300 programs that cover a wide spectrum of health-related activities.
Funding for the PHS agencies is provided through three different appropriations acts. Total
discretionary appropriations to these agencies for FY2008 totaled $50.6 billion.
For each of the PHS agencies, this report describes the mission, organization, key programs,
history, and legislative authorities, and provides budget tables for FY2007 through the FY2009
request. It will be updated as legislative and other events warrant.

˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
˜—?Ž—?œȱ
Overview and History of the Public Health Service........................................................................ 1
Agency for Healthcare Research and Quality (AHRQ) .................................................................. 5
Mission...................................................................................................................................... 5
Organization and Key Programs ............................................................................................... 5
History and Legislative Authorities........................................................................................... 7
Centers for Disease Control and Prevention (CDC)/Agency for Toxic Substances and
Disease Registry (ATSDR)........................................................................................................... 9
Mission...................................................................................................................................... 9
Organization and Key Programs ............................................................................................... 9
History and Legislative Authorities..........................................................................................11
Food and Drug Administration...................................................................................................... 13
Mission.................................................................................................................................... 13
Organization and Key Programs ............................................................................................. 14
History and Legislative Authorities......................................................................................... 15
Health Resources and Services Administration (HRSA) .............................................................. 18
Mission.................................................................................................................................... 18
Organization and Key Programs ............................................................................................. 19
History and Legislative Authorities......................................................................................... 20
Indian Health Service (IHS) .......................................................................................................... 23
Mission.................................................................................................................................... 23
Organization and Key Programs ............................................................................................. 23
History and Legislative Authorities......................................................................................... 24
National Institutes of Health (NIH) ............................................................................................... 26
Mission.................................................................................................................................... 26
Organization and Key Programs ............................................................................................. 27
History and Legislative Authorities......................................................................................... 29
Substance Abuse and Mental Health Services Administration (SAMHSA) ................................. 31
Mission.................................................................................................................................... 31
Organization and Key Programs ............................................................................................. 32
History and Legislative Authorities......................................................................................... 33
Additional Congressional Research Service (CRS) Reports ......................................................... 35
Links to Selected Reports on Current Legislative Issues ........................................................ 35

Š‹•Žœȱ
Table 1. Titles in the Public Health Service Act .............................................................................. 1
Table 2. Public Health Service (PHS) Agency Budgets: Summary Table....................................... 4
Table 3. Agency for Healthcare Research and Quality (AHRQ)..................................................... 8
Table 4. Centers for Disease Control and Prevention (CDC)/Agency for Toxic Substances
and Disease Registry (ATSDR) .................................................................................................. 12
Table 5. Food and Drug Administration (FDA) ............................................................................ 17
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
Table 6. Health Resources and Services Administration (HRSA)................................................. 21
Table 7. Indian Health Service (IHS) ............................................................................................ 25
Table 8. National Institutes of Health (NIH) ................................................................................. 30
Table 9. Substance Abuse and Mental Health Services Administration (SAMHSA).................... 34

˜—?ŠŒ?œȱ
Author Contact Information .......................................................................................................... 36
Key Policy Staff ............................................................................................................................ 36

˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
ŸŽ›Ÿ’Ž ȱŠ—?ȱ ’œ?˜›¢ȱ˜?ȱ?‘Žȱž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱ
The Public Health Service Act (PHS Act) authorizes programs for the conduct, support, and
coordination of “research, investigations, experiments, demonstrations, and studies relating to the
causes, diagnosis, treatment, control, and prevention of physical and mental diseases and
impairments of man, including water purification, sewage treatment, and pollution of lakes and
streams.”1 The Department of Health and Human Services (HHS) is the executive branch
department responsible for carrying out the provisions of the PHS Act.
The Public Health Service originated in an act of July 16, 1798. That act authorized marine
hospitals to care for American merchant seamen. Over the years, the scope and responsibilities of
the PHS Act and the Service have broadened. The Public Health Service Act of July 1, 1944,
revised and consolidated into one law all legislation existing at that time relating to programs and
activities of the PHS. The act has been amended and extended nearly every year since 1944 and
currently includes 29 titles. A list of titles in the act is provided in Table 1. A compilation of the
PHS Act, as amended through December 31, 2004, is available at
http://energycommerce.house.gov/108/pubs/109_health.pdf.
Table 1. Titles in the Public Health Service Act
Title I
Short Title and Definitions
Title II
Administration and Miscellaneous Provisions
Title III
General Powers and Duties of Public Health Service
Title IV
National Research Institutes
Title V
Substance Abuse and Mental Health Services Administration
Title VI
Assistance for Construction and Modernization of Hospitals and Other Medical Facilities
Title VII
Health Professions Education
Title VIII
Nursing Workforce Development
Title IX
Agency for Healthcare Research and Quality
Title X
Population Research and Voluntary Family Planning Programs
Title XI
Genetic Diseases, Hemophilia Programs, and Sudden Infant Death Syndrome
Title XII
Trauma Care
Title XIII
Health Maintenance Organizations
Title XIV
Safety of Public Water Systems
Title XV
Preventive Health Measures with Respect to Breast and Cervical Cancers
Title XVI
Health Resources Development
Title XVII
Health Information and Health Promotion
Title XVIII
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and
Behavioral Research
Title XIX
Block Grants

1 Section 301 of the PHS Act, codified at 42 U.S.C. § 241(a).
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
Title I
Short Title and Definitions
Title XX
Adolescent Family Life Demonstration Projects
Title XXI
Vaccines
Title XXII
Requirements for Certain Group Health Plans for Certain State and Local Employees
Title XXIII
Research with Respect to Acquired Immune Deficiency Syndrome
Title XXIV
Health Services with Respect to Acquired Immune Deficiency Syndrome
Title XXV
Prevention of Acquired Immune Deficiency Syndrome
Title XXVI
HIV Health Care Services Program
Title XXVII Assuring Portability, Availability, and Renewability of Health Insurance Coverage
Title XXVIII National Preparedness for Bioterrorism and Other Public Health Emergencies
Title XXIX
Lifespan Respite Care
Sources: Compiled by CRS from U.S. House of Representatives, Committee on Energy and Commerce,
Compilation of Selected Acts Within the Jurisdiction of the Committee on Energy and Commerce: Health Law, August
2005 http://energycommerce.house.gov/108/pubs/109_health.pdf, and P.L. 109-442, Lifespan Respite Care Act
of 2006.
Reorganization Plan No. 3 of 1966 transferred all statutory power and functions of the Surgeon
General and other officers and agencies of the PHS to the Secretary of Health, Education, and
Welfare (HEW).2 In 1979, the Department of Education Organization Act (P.L. 96-88) provided
for a separate Department of Education, and HEW was officially redesignated as HHS on May 4,
1980. HHS has designated eight agencies as Public Health Service operating divisions.3 Those
agencies are
• the Agency for Healthcare Research and Quality (AHRQ),
• the Agency for Toxic Substances and Disease Registry (ATSDR),
• the Centers for Disease Control and Prevention (CDC),
• the Food and Drug Administration (FDA),
• the Health Resources and Services Administration (HRSA),
• the Indian Health Service (IHS),
• the National Institutes of Health (NIH), and
• the Substance Abuse and Mental Health Services Administration (SAMHSA).
The Agency for Toxic Substances and Disease Registry is administered by the Director of the
CDC, and the two agencies are discussed together in this report.
The missions and key functions of the PHS agencies vary. Two of them principally conduct and
support research: NIH conducts and supports basic, clinical, and translational medical research,

2 The House and Senate held hearings on President Johnson’s reorganization plan, but no further legislative action was
taken. The plan became effective June 25, 1966, 80 Stat. 1610.
3 The HHS “family of agencies” also includes the following, which are not part of the PHS: Office of the Secretary,
Administration for Children and Families, Administration on Aging, and Centers for Medicare and Medicaid Services.
See links at http://www.hhs.gov/.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
Řȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
and AHRQ conducts and supports research on the quality and effectiveness of health care services
and systems. One agency, IHS, provides or directly funds health care services for members of the
nation’s federally recognized Indian tribes. Two agencies support the provision of health care
services, or the systems that provide them, for a number of other special populations: HRSA funds
programs and systems to improve access to health care among low-income populations, pregnant
women and children, persons living with HIV/AIDS, rural and frontier populations, and others,
and SAMHSA funds programs and systems that provide mental health and substance abuse
prevention and treatment services. CDC/ATSDR develops and supports public health prevention
programs and systems, such as disease surveillance and provider education programs, for a full
spectrum of acute and chronic diseases and injuries, including public health emergencies such as
bioterrorism. Although the agencies above have limited regulatory responsibilities, if any, the
FDA’s mission is almost entirely regulatory, ensuring the safety of foods and the safety and
effectiveness of drugs, vaccines, medical devices, and other health products.
Table 2 presents total budgets for each of the agencies for FY2007 through the FY2009 request.
Detailed budget tables are provided with each agency discussion. Five of the agencies (AHRQ,
CDC, HRSA, NIH, and SAMHSA) receive the bulk of their funding through the annual
appropriations act for the Departments of Labor, Health and Human Services, Education, and
Related Agencies (Labor-HHS-ED). ATSDR and IHS funds are provided through the Interior,
Environment, and Related Agencies appropriation, and FDA receives its funding through the
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
appropriation. As part of the President’s annual budget proposal, HHS presents a common request
for all of its components. Documents supporting the HHS budget request for FY2009, including a
summary called the Budget in Brief and links to the “Congressional justification” materials
prepared for the Appropriations Committees, may be found at http://www.hhs.gov/budget/
docbudget.htm.
The PHS Evaluation Set-Aside, also called the PHS Evaluation Tap, is a unique budget transfer
feature for agencies and offices authorized by the PHS Act and funded by the Labor-HHS-ED
appropriations act. Section 241 of the PHS Act (42 U.S.C. § 238j) authorizes the Secretary to use
a portion of eligible appropriations to assess the effectiveness of federal health programs and to
identify ways to improve them. Funds are also used for activities that support the infrastructure
for evaluation of health programs, such as data-gathering and analysis. Although the PHS Act
limits the set-aside to no more than 1% of program appropriations, in recent years the annual
Labor-HHS-ED appropriations act has specified a higher maximum amount of funds that may be
set aside for evaluation (currently 2.4% of the eligible portions of agency budgets).4
HHS identifies the amount of set-aside funds to be “tapped,” primarily from the appropriations of
NIH, HRSA, CDC, and SAMHSA, and determines the amount of funding to be made available to
each “recipient” agency or program, including several offices within the Office of the HHS
Secretary. Many of the recipient programs are specified by Congress in the appropriations act.

4 The current provision is found in § 206 of the FY2008 Labor-HHS-ED appropriations act, P.L. 110-161, Division G.
Most of the funds appropriated for CDC, HRSA, NIH, and SAMHSA are subject to the PHS evaluation tap.
Exceptions, by HHS convention, include funds appropriated for certain block grants (Prevention, Substance Abuse, and
Mental Health), for program management activities, and for Buildings and Facilities, as well as some programs not
authorized by the PHS Act, such as the Maternal and Child Health Block Grant in HRSA. For further details, see Use of
Public Health Service Evaluation Set-Aside Authority for FY 2005, available at http://aspe.hhs.gov/rcc/SetAsideReport/
FY2005.pdf, and Evaluation in the Department of Health and Human Services, available at http://aspe.hhs.gov/pic/
perfimp/2002/appendixa.htm.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
řȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
The entire budget of AHRQ is funded through the evaluation set-aside, and selected programs in
the other four agencies also receive funds through this transfer mechanism. See the individual
agency budget tables for specifics.
For each of the PHS agencies, this report describes the mission, organization, key programs,
history, and legislative authorities, and provides budget tables for FY2007 through the FY2009
request. It will be updated as legislative and other events warrant.
Table 2. Public Health Service (PHS) Agency Budgets: Summary Table
(dollars in millions)
FY2007
FY2008
FY2009 Pres.
% change FY09 vs.
Agencies
actual
enacted
request
FY08
Agency for Healthcare Research and Quality (AHRQ)
Discretionary budget
authority
0 0 0
0.0%
Total program level
319
335
326
-2.7%
Centers for Disease Control and Prevention (CDC)/
Agency for Toxic Substances and Disease Registry (ATSDR)
Discretionary budget
authority
6,060 6,124 5,691
-7.1%
Total program level
9,116
9,209
8,797
-4.5%
Food and Drug Administration (FDA)
Discretionary budget
authority
1,583 1,720 1,771
2.9%
Total program level
1,974
2,270
2,400
5.7%
Health Resources and Services Administration (HRSA)
Discretionary budget
authority
6,398 6,864 5,872
-14.5%
Total program level
6,447
6,917
5,922
-14.4%
Indian Health Service (IHS)
Discretionary budget
authority
3,180 3,346 3,325
-0.6%
Total program level
4,103
4,282
4,261
-0.5%
National Institutes of Health (NIH)
Discretionary budget
authority
28,978 29,307 29,307
0.0%
Total program level
29,038
29,171
29,165
0.0%
Substance Abuse and Mental Health Services Administration (SAMHSA)
Discretionary budget
authority
3,206 3,234 3,025
-6.5%
Total program level
3,327
3,356
3,159
-5.9%
Total for PHS Agenciesa
Discretionary budget
49,405
50,596
48,991
-3.2%
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
Śȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
FY2007
FY2008
FY2009 Pres.
% change FY09 vs.
Agencies
actual
enacted
request
FY08
authority
Source: Derived from agency tables in this report (Table 3 through Table 9).
Note: Totals and percentages may not compute exactly due to rounding.
a.
AHRQ is financed through PHS evaluation funds, which come from the appropriations of other agencies.
Therefore, AHRQ is not included in the total for discretionary budget authority. (A total program level for
PHS agencies cannot be calculated without additional information on the distribution of PHS evaluation
funds across multiple HHS agencies.)
?Ž—Œ¢ȱ?˜›ȱ ŽŠ•?‘ŒŠ›ŽȱŽœŽŠ›Œ‘ȱŠ—?ȱžŠ•’?¢ȱ
ǻ Ǽȱ
’œœ’˜—ȱ
The Agency for Healthcare Research and Quality (AHRQ) is the lead agency charged with
supporting research designed to improve the quality of health care, to increase the efficiency of its
delivery, and to broaden access to the most essential health services. To accomplish these goals, it
funds, conducts, and disseminates research aimed at reducing the costs of care, promoting patient
safety, and increasing the effectiveness of health care services.
›?Š—’£Š?’˜—ȱŠ—?ȱŽ¢ȱ›˜?›Š–œȱ
The agency is divided into nine major functional components, consisting of four offices and five
research centers. The offices, centers, and key program areas are described below.5 Unlike the
National Institutes of Health (NIH) or the Centers for Disease Control and Prevention (CDC),
which each have separate funding streams for major organizational entities such as centers or
institutes, AHRQ funds are targeted to specific programs or objectives (e.g., comparative
effectiveness, patient safety, and health disparities). Budget dollars are then allocated to AHRQ’s
centers by the Director, according to research priorities identified by Congress or the Department
of Health and Human Services. Therefore, Table 3, which describes AHRQ’s budget, does not
provide funding stream data for the separate research centers at AHRQ. Instead, budget figures
are displayed according to several broad program categories, also described below.
Offices and Research Centers
The Office of the Director is charged with ensuring that AHRQ’s strategic objectives are
achieved. The Office of Performance Accountability, Resources, and Technology coordinates
agency-wide program planning and administrative operations. The Office of Extramural
Research, Education, and Priority Populations (OEREP) directs the scientific review process,
manages AHRQ’s research training programs, monitors and evaluates ongoing research, and
supports or conducts studies on priority populations and health disparity populations. The Office

5 For additional information, see http://www.ahrq.gov/about/offcntrs.htm.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
śȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
of Communications and Knowledge Transfer implements and manages programs for
disseminating the results of AHRQ activities and AHRQ-funded research.
The Center for Outcomes and Evidence (COE) conducts and supports research, assessments, and
demonstrations on safety, quality, effectiveness, and cost-effectiveness. It serves as a repository
for evidence-based information on therapeutics, technologies, and health care practices. COE
summarizes these findings and provides an array of tools and products to promote and facilitate
evidence-based clinical decisions. The Center for Primary Care, Prevention, and Clinical
Partnerships (CP3) focuses on research addressing the effectiveness and quality of primary and
preventive health care services. CP3 serves as a locus for research on health information
technology. It also supports work on the preparedness of the health care system to deal with
bioterrorism, natural disasters, and pandemic flu. The Center for Delivery, Organization, and
Markets (CDOM) conducts and supports qualitative and quantitative studies on how
organizational dynamics in the health sector affect access and costs. For instance, its research
examines how market forces influence payment methods, financial and non-financial incentives,
safety net funding, and employer purchasing strategies. The Center for Financing, Access, and
Cost Trends (CFACT) manages studies of the cost and financing of health care, including
research analyzing trends and patterns of health expenditures, public and private insurance
coverage, utilization of care, and access to care for various subsets of the general population.
CFACT’s work includes modeling and projections of health care use, population health status,
and overall health care expenditures. The Center for Quality Improvement and Patient Safety
(CQuIPS) supports research addressing patient safety, including studies on health care quality
measurement and medical error reporting. In addition, it develops and disseminates reports aimed
at decreasing medical errors, risks, and hazards in health care settings.
Program Areas
The AHRQ budget, presented in Table 3, is organized according to program areas. These are (1)
Research on Healthcare Costs, Quality and Outcomes (HQCO), which consists of patient safety
research, and non-patient safety research; (2) the Medical Expenditure Panel Survey; and (3)
program support.
Medical errors result in considerable morbidity, mortality, and costs to the health care system.
With the increased focus on patient safety stimulated by the release of the Institute of Medicine’s
1999 report, To Err Is Human, and with a substantial budget increase from Congress directed
toward patient safety, AHRQ embarked on a strategic approach to develop a large, targeted
patient safety research initiative. The ongoing objectives of this effort include developing public-
private partnerships to build capacity for medical error reduction activities, examining the effect
of working conditions on patient safety, and reviewing different methods of reporting medical
errors.
Among its patient safety research programs, AHRQ is actively involved with researching the
advantages and disadvantages associated with health information technology (HIT). HIT broadly
refers to the use of computers and computer programs to store, protect, retrieve, and transfer
clinical, administrative, and financial information electronically within health care settings.
Clinicians and researchers believe that electronic health records could play an important role in
coordinating care, especially for people with chronic conditions, such as diabetes or asthma, who
frequently see multiple providers. An AHRQ priority is the dissemination of new knowledge and
best practices from pioneers in this field.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
Ŝȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
Nearly 60% of AHRQ’s budget is awarded as grants and contracts to researchers at universities
and other research institutions for the purpose of studying issues other than patient safety.
Recently, AHRQ has placed a high priority on research regarding the care of individuals with
chronic conditions and/or multiple co-morbidities. It has expressed a particular interest in funding
studies of patient-centered care that evaluate different efforts to redesign structural processes to
target sicker individuals. This includes interventions that empower patients, improve patient-
provider communication, and facilitate the coordination of care, such as telehealth, electronic
health records, disease-management programs, medication therapy compliance programs, and
Web-based applications for patients and health care providers. AHRQ has also devoted
considerable resources to eliminating health disparities, investigating strategies to reduce racial,
ethnic, and socioeconomic inequities in access to health care services. To this end, it produces an
annual report to Congress, the National Healthcare Disparities Report.6
The comparative effectiveness program, which helps policy makers, clinicians, and patients
determine which medical treatments work best for certain health conditions, grew out of Section
1013 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (P.L. 108-
173). The program supports the development of new scientific information through research on
the outcomes of health care services and therapies, including pharmaceuticals, and by comparing
different therapies used to treat the same condition.7
Cosponsored by AHRQ and the National Center for Health Statistics in CDC, the Medical
Expenditure Panel Survey (MEPS) is a survey of health care use by the civilian population living
in the United States. MEPS produces nationally representative statistics on health care utilization
and expenditures. It also collects data on health conditions, health insurance, and coverage.
MEPS is composed of three different but related surveys: the Household Component (HC), the
Medical Provider Component (MPC), and the Insurance Component (IC). The MEPS HC Survey
collects detailed data on demographic characteristics, health conditions, health status, access to
care, satisfaction with care, and health insurance coverage. The MPC Survey supplements and
validates information on medical care events reported in the MEPS HC by contacting medical
providers and pharmacies identified by household respondents. Lastly, the IC Survey collects data
on health insurance plans obtained through private and public-sector employers.8
’œ?˜›¢ȱŠ—?ȱŽ?’œ•Š?’ŸŽȱž?‘˜›’?’Žœȱ
AHRQ has evolved from a succession of agencies concerned with fostering health services
research and health care technology assessment. The Omnibus Budget Reconciliation Act of 1989
(P.L. 101-239) added a new Title IX to the PHS Act and established the Agency for Health Care
Policy and Research (AHCPR), a successor agency to the former National Center for Health
Services Research and Health Care Technology Assessment (NCHSR). AHCPR was reauthorized
in 1992 (P.L. 102-410).
On December 6, 1999, President Clinton signed the Healthcare Research and Quality Act of 1999
(P.L. 106-129), which renamed AHCPR as the Agency for Healthcare Research and Quality
(AHRQ) and reauthorized it through FY2005. The new name was intended to underscore that

6 See http://www.ahrq.gov/qual/nhdr06/nhdr06.htm.
7 For more information, see http://www.effectivehealthcare.ahrq.gov.
8 For more information about MEPS, see http://www.meps.ahrq.gov/mepsweb.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŝȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
AHRQ is a scientific research agency, not an entity that determines federal health care policies
and regulations. The word “Quality” was added to the agency’s name to emphasize its lead role in
coordinating all federal health care quality improvement efforts.
Table 3 presents funding levels for AHRQ programs for FY2007 through FY2009. As described
in the introduction to this report, AHRQ receives all of its funding through the PHS Evaluation
Set-Aside, rather than through provision of new budget authority in appropriations.
Table 3. Agency for Healthcare Research and Quality (AHRQ)
(dollars in millions)
FY2007
FY2008
FY2009 Pres.
% change FY09
Activities
actual
enacted
request
vs. FY08
Research on Health Costs, Quality, and Outcomes (HCQO)
Budget Authority
0
0
0
0.0%
PHS Evaluation Tap fundinga 261 277 268
-3.3%
Patient Safety Research (non-add)b (34) (34)
(32)
-6.0%
Health Information Technology (non-
(50) (45) (45)
0.0%
add)b
Total AHRQ patient safety program
(84) (79) (77)
-2.7%
(non-add)b
Comparative Effectiveness (non-add)
(15)
(30)
(30)
0.0%
Medical Expenditure Panel Surveys (MEPS)
Budget Authority
0
0
0
0.0%
PHS Evaluation Tap fundinga 55 55 55
0.0%
Program Support
Budget Authority
0
0
0
0.0%
PHS Evaluation Tap fundinga 3 3
3

0.0%
Total, AHRQ discretionary
0 0 0

0.0%
budget authority
Total, PHS Evaluation Tap fundinga 319
335
326
-2.7%
Total, AHRQ program level
319
335
326
-2.7%
Source: Adapted by CRS from AHRQ, Justification of Estimates for Appropriations Committees, Fiscal Year 2009, at
http://www.ahrq.gov/about/cj2009/cj2009.pdf.
Note: Totals and percentages may not compute exactly due to rounding.
a. AHRQ receives its entire funding through transfers from other PHS agencies under the PHS Evaluation Set-
Aside (§ 241 of the PHS Act).
b. AHRQ’s patient safety program includes both Patient Safety Research and Health Information Technology.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
Şȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
Ž—?Ž›œȱ?˜›ȱ’œŽŠœŽȱ˜—?›˜•ȱŠ—?ȱ›ŽŸŽ—?’˜—ȱȱ
ǻǼȦ?Ž—Œ¢ȱ?˜›ȱ˜¡’Œȱž‹œ?Š—ŒŽœȱŠ—?ȱ’œŽŠœŽȱȱ
ȱŽ?’œ?›¢ȱǻǼȱ
’œœ’˜—ȱ
According to the Centers for Disease Control and Prevention (CDC), its mission is “to promote
health and quality of life by preventing and controlling disease, injury, and disability.”9 CDC is
the nation’s principal public health agency, providing coordination and support for a variety of
population-based disease and injury control activities. Approximately 75% of the agency’s
funding is spent extramurally through grants, contracts, and cooperative agreements to various
stakeholders, including state, local, municipal, and foreign governments, non-profit organizations,
academic institutions, and others. Upon the request and under the authority of a state or foreign
government, CDC provides technical assistance, including workforce support, specialized
laboratory services, data management, and other services to support public health investigations.
The agency does not directly deliver either health care or public health services to individuals.
CDC coordinates, analyzes, and disseminates public health information derived from a number of
health surveys and disease surveillance systems that it manages. The information may be used to
develop public health recommendations, such as immunization schedules for children. CDC also
publishes several peer-reviewed journals, including Morbidity and Mortality Weekly Report
(MMWR), a weekly journal reporting on public health investigations and surveillance findings.
CDC performs many of the administrative functions for the Agency for Toxic Substances and
Disease Registry (ATSDR), and the Director of CDC serves as the Administrator of ATSDR.
Congress established ATSDR in 1980 in the Comprehensive Environmental Response,
Compensation, and Liability Act (CERCLA, P.L. 96-510, the “Superfund” law) to investigate and
reduce the harmful effects of exposure to hazardous substances on human health.10
›?Š—’£Š?’˜—ȱŠ—?ȱŽ¢ȱ›˜?›Š–œȱ
The current structure of CDC was implemented in April 2005 in a reorganization called “The
Futures Initiative.”11 The agency has more than 8,500 permanent employees and approximately
6,000 contract employees.12 CDC occupies several main campuses in Atlanta, GA, and several
other sites, including locations in Colorado, Maryland, Ohio, West Virginia, and Washington, DC.
The agency’s organizational components are described below.
• The Office of the Director manages and directs agency activities.

9 See the CDC website at http://www.cdc.gov/.
10 See “Public Health Issues and the Agency for Toxic Substances and Disease Registry,” in CRS Report 97-312,
Superfund Fact Book, by Mark Reisch and David M. Bearden.
11 See http://www.cdc.gov/futures/ and the CDC organizational chart at http://www.cdc.gov/about/organization/
orgChart.htm.
12 See CDC’s current annual report, The State of CDC, FY2006, p. 35, at http://www.cdc.gov/about/stateofcdc/cdrom/
SOCDC/SOCDC2006.pdf.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
şȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
• The Coordinating Center for Environmental Health and Injury Prevention
houses two operating divisions. The National Center for Environmental
Health/Agency for Toxic Substances and Disease Registry (NCEH-ATSDR)
provides national leadership in preventing and controlling disease and death
resulting from the interactions between people and their environment. The
National Center for Injury Prevention and Control (NCIPC) works to prevent
death and disability from non-occupational injuries, including those that are
unintentional (e.g., falls, fires, drowning, poisoning, and motor vehicle crashes)
and those that result from violence (e.g., homicide, suicide, and domestic
violence).
• The Coordinating Center for Health Information and Service houses three
operating divisions. The National Center for Health Statistics (NCHS) provides
statistical information that guides public health policy and activities. The
National Center for Public Health Informatics (NCPHI) provides leadership in
the application of information technology to public health. The National Center
for Health Marketing (NCHM) provides leadership in health marketing science
and in its application to public health.
• The Coordinating Center for Health Promotion houses three operating
divisions. The National Center on Birth Defects and Developmental Disabilities
(NCBDDD) provides national leadership for preventing birth defects and
developmental disabilities and for improving the health and wellness of people
with disabilities. The National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP) works to prevent premature death and disability
from chronic diseases such as heart disease, cancer, diabetes, and arthritis, and
promotes healthy personal behaviors. The Office of Genomics and Disease
Prevention provides national leadership in fostering understanding of human
genomic discoveries and how they can be used to improve health and prevent
disease.
• The Coordinating Center for Infectious Diseases houses four operating
divisions. The National Center for Immunization and Respiratory Diseases
(NCIRD) supports research and programs for vaccine-preventable diseases. The
National Center for Zoonotic, Vector-Borne, and Enteric Diseases (NCZVED)
works to prevent illness, disability, and death caused by infectious diseases
domestically and globally. The National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP) provides national leadership in preventing
and controlling human immunodeficiency virus (HIV) infection, sexually
transmitted diseases, and tuberculosis. The National Center for Preparedness,
Detection, and Control of Infectious Diseases (NCPDCID) focuses on improving
preparedness and response capacity for new and complex infectious disease
outbreaks.
• The Coordinating Office for Global Health provides national leadership,
coordination, and support for CDC’s global health activities, in collaboration
with global health partners.
• The Coordinating Office for Terrorism Preparedness and Emergency
Response (COTPER) provides strategic direction for CDC to support terrorism
preparedness and emergency response efforts.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗŖȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
• The National Institute for Occupational Safety and Health (NIOSH) ensures
safety and health for all people in the workplace through research and prevention.
’œ?˜›¢ȱŠ—?ȱŽ?’œ•Š?’ŸŽȱž?‘˜›’?’Žœȱ
In 1946, the Communicable Disease Center was created from the Office of Malaria Control in
War Areas, in Atlanta, GA. The original agency was established in 1942 to control malaria and
other mosquito-borne diseases in U.S. military personnel training in the southeastern United
States. In 1970, CDC was renamed the Center for Disease Control to reflect its added
responsibilities for noncommunicable diseases. CDC’s mission continued to expand to include
programs in occupational and environmental health, family planning and reproductive health, and
chronic diseases. A major reorganization in 1980, and its renaming to the Centers for Disease
Control, emphasized the importance of health promotion and education in the agency’s mission.
In 1992, Congress added the words “and Prevention” to the agency’s name, to recognize its role
in the prevention of disease, injury, and disability. In enacting the change, Congress specified that
the agency may continue to use the acronym “CDC” because of its recognition within the public
health community and among the public.13
Many of CDC’s activities are not specifically authorized but are based in broad, permanent
authorities in the PHS Act. For example, Section 301 authorizes the Secretary of HHS to conduct
research and investigations as necessary to control disease; Section 307 authorizes the Secretary
to cooperate with and provide assistance to foreign nations; and Section 317 authorizes the
Secretary to award grants to states for preventive health programs. Some other CDC programs
(e.g., lead poisoning prevention) are explicitly authorized in the PHS Act, primarily in Title III.
Four CDC operating divisions are explicitly authorized in statute. NIOSH was established in
permanent authority in the Occupational Safety and Health Act of 1970.14 The National Center on
Birth Defects and Developmental Disabilities was established in Section 317C of the PHS Act by
the Children’s Health Act of 2000. Its appropriations authority expired in 2007.15 The National
Center for Health Statistics was established in Section 306 of the PHS Act by the Health Services
Research, Health Statistics, and Medical Libraries Act of 1974. Its appropriations authorities
expired in FY2002 and FY2003. ATSDR was established in the Comprehensive Environmental
Response, Compensation and Liability Act of 1980 (CERCLA).16 Its appropriations authority
expired in 1994.17 NCBDDD, NCHS, and ATSDR have continued to receive annual
appropriations despite their expired authorities.
CDC has few regulatory authorities. Public health regulatory authorities, such as professional
licensing, facility inspection, quarantine, and contact tracing, are generally based in state law.
CDC’s limited regulatory authorities include certain authorities to regulate laboratories in which

13 Information on CDC history is available in Centers for Disease Control and Prevention, “CDC: The Nation’s
Prevention Agency,” MMWR, vol. 41, no. 44 (November 6, 1992), p. 834.
14 29 U.S.C. § 671.
15 42 U.S.C. § 247b-4.
16 42 U.S.C. § 9604(i).
17 42 U.S.C. § 9611(m).
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗŗȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
potential bioterrorism agents are handled, and authority for disease control functions concerning
entries of persons, goods, and conveyances from other countries.18
Most CDC programs are funded through the Departments of Labor, Health and Human Services,
Education, and Related Agencies (L-HHS-ED) annual appropriation. ATSDR is funded separately
from other CDC programs, in the Interior, Environment, and Related Agencies annual
appropriation. Table 4 presents funding levels for CDC programs for FY2007 through FY2009.
Occasionally, upon the request of the chairman of a Labor, Health and Human Services,
Education, and Related Agencies Appropriations Subcommittee, the CDC Director will submit
directly to the chairman a “professional judgment” budget, outside of the usual budget request
published by the White House Office of Management and Budget in February of each year. A
CDC “professional judgment” budget for FY2008 requested almost $1 billion above the agency’s
FY2007 level.19
Table 4. Centers for Disease Control and Prevention (CDC)/Agency for Toxic
Substances and Disease Registry (ATSDR)
(dollars in millions)
FY2007
FY2008
FY2009 Pres.
% change FY09
Programs
actual
enacted
request
vs. FY08
Infectious Diseases, budget authority
1,797 1,892 1,857
-1.8%
(BA)
Pandemic and seasonal influenza (non-
(73) (157) (160)
1.8%
add)a
PHS Evaluation Tap fundingb 13
13
13 0.0%
Infectious Diseases, program level
1,810
1,905
1,870
-1.8%
Health Promotion, BA
947
961
932
-3.0%
Health Information and Service, BA
136
90
133
48.0%
PHS Evaluation Tap fundingb 134
187
151
-19.0%
Health Information and Service,
270 277 284
2.7%
program level
Environmental Health and Injury, BA
283
289
271
-6.4%
Occupational Safety and Health, BA
228
287
184
-36.0%
PHS Evaluation Tap fundingb 87
95
87 -7.9%
Occupational Safety and Health,
315 382 271 -29.0%
program level
Global Health, BA
307
302
302
0.1%
Public Health Research, BA
0
0
0
0.0%
PHS Evaluation Tap fundingb 31
31
31 0.0%
Public Health Research, program level
31
31
31
0.0%

18 For more information, see CRS Report RL34144, Extensively Drug-Resistant Tuberculosis (XDR-TB): Emerging
Public Health Threats and Quarantine and Isolation, by Kathleen S. Swendiman and Nancy Lee Jones.
19 See http://www.fundcdc.org/documents/CDCFY2008PJ_000.pdf.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗŘȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
FY2007
FY2008
FY2009 Pres.
% change FY09
Programs
actual
enacted
request
vs. FY08
Public Health Improvement and
203 225 182 -19.0%
Leadership, BA
Prev. Health and Health Services Block
99 97 0 -100.0%
Grant, BA
Buildings and Facilities, BA
134
55
0
-100.0%
Business Services Support, BA
378
372
338
-9.1%
Terrorism, BA
1,473
1,479
1,419
-4.1%
Subtotal, Labor-HHS-ED
5,985 6,050 5,618
-7.1%
discretionary BA
ATSDR, BA (Interior/Environment
75 74 73 -1.6%
appropriations)
Subtotal, CDC/ATSDR
6,060 6,124 5,691
-7.1%
discretionary BA
Total, PHS Evaluation Tap fundingb 265 326
283
-13.2%
Vaccines for Children (VFC)c 2,736
2,702
2,766 2.4%
EEOICPAd (proposed)
52
55
55
0.0%
User feese 2
2
2
0.0%
Total, CDC/ATSDR program
9,116 9,209 8,797
-4.5%
level
Source: Adapted by CRS from CDC, Budget Request Summary, Fiscal Year 2009, FY2009 Discretionary All-
Purpose Table, pp. 16-18, at http://www.cdc.gov/fmo/fmofybudget.htm.
Note: Totals and percentages may not compute exactly due to rounding. BA is budget authority, the
discretionary appropriation for the program. Program level is the total available funding for the program.
a. Levels reflect a proposed consolidation of influenza funding. For the FY2009 request, CDC has consolidated
all funding for pandemic and seasonal influenza within the Infectious Diseases budget rather than displaying it
within several budget categories. FY2007 and FY2008 amounts reflect comparable funding.
b. Funds from PHS Evaluation Set-Aside (§ 241 of the PHS Act).
c. The Vaccines for Children (VFC) program provides free pediatric vaccines to doctors who serve eligible
children. The VFC program is funded entirely by federal Medicaid appropriations and is administered by
CDC’s National Center for Immunization and Respiratory Diseases.
d. EEOICPA is the Energy Employees Occupational Illness Compensation Program Act. The FY2009 request
includes an additional $55 million in mandatory funding to support required activities that are carried out by
NIOSH. Prior to FY2009, funding for these activities was provided by the Department of Labor through an
interagency agreement. The FY2007 and FY2008 amounts reflect comparable funding.
e. CDC is authorized to collect fees from researchers and others who use certain of the agency’s databases.
˜˜?ȱŠ—?ȱ›ž?ȱ?–’—’œ?›Š?’˜—ȱ
’œœ’˜—ȱ
The Food and Drug Administration (FDA) website, at http://www.fda.gov, has a brief statement
of its mission:
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗřȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
• To promote and protect the public health by helping safe and effective products
reach the market in a timely way.
• To monitor products for continued safety after they are in use.
• To help the public get the accurate, science-based information needed to improve
health.
›?Š—’£Š?’˜—ȱŠ—?ȱŽ¢ȱ›˜?›Š–œȱ
FDA regulates more than $1 trillion worth of products, which account for 25 cents of every dollar
spent annually by American consumers. It regulates the safety of foods (including animal feeds)
and the safety and effectiveness of drugs, biologics (e.g., vaccines), and medical devices.
The organization charts of FDA overall and its components are available at http://www.fda.gov/
opacom/7org.html. Six centers within FDA represent the broad program areas for which the
agency has responsibility; other offices have agency-wide responsibilities:
• The Office of the Commissioner is responsible for agency-wide management of
policies and activities. http://www.fda.gov/oc/default.htm
• The Center for Biologics Evaluation and Research (CBER) is responsible for
the safety of the nation’s blood supply and routinely examines blood bank
operations for record keeping and testing for contaminants. It also ensures the
safety, purity, and effectiveness of biologics (medical preparations made from
living organisms and their products), such as insulin and vaccines.
http://www.fda.gov/cber/.
• The Center for Devices and Radiological Health (CDRH) regulates medical
devices. The marketing approval process varies based on two criteria: (1)
whether a device is new, which requires demonstration of safety and
effectiveness, or substantially equivalent to an approved device, and (2) which of
three classes of risk to the public that FDA assigns to it. http://www.fda.gov/cdrh/
• The Center for Drug Evaluation and Research (CDER) evaluates new drug
applications; no prescription drug can enter interstate commerce unless and until
FDA determines, based on data from clinical trials, that it is safe and effective
when used for the population and clinical condition described in its labeling. In
addition to this premarket review, FDA is responsible for the postmarket safety
and effectiveness of approved products. It has some authority to influence direct-
to-consumer advertising; review adverse event reports from manufacturers,
clinicians, consumers, and studies described by manufacturers or in peer-
reviewed journals; and alert clinicians or the public to newly identified possible
risks. FDA follows similar procedures for changes in labeling and dosage or
other modifications to an approved product, and for nonprescription drugs. In
addition to direct appropriations, user fees paid by pharmaceutical companies
support CDER’s premarket review and, to a lesser extent, postmarket safety
activities. http://www.fda.gov/cder/
• The Center for Food Safety and Applied Nutrition (CFSAN) is responsible
for protecting the safety and wholesomeness of the human food supply, except
for meat and poultry products, which are regulated by the U.S. Department of
Agriculture. It preapproves for safety the addition of certain chemicals to food
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗŚȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
products (such as food and color additives). CFSAN tests food samples to
determine whether any substances, such as pesticide residues or heavy metals,
are present in unacceptable amounts. It also sets standards for label information
to assist consumers in knowing what is present in the foods they are buying. In
addition, CFSAN regulates the safety and labeling of cosmetics.
http://www.cfsan.fda.gov/list.html
• The Center for Veterinary Medicine (CVM) regulates animal drugs and
devices to ensure safety and effectiveness, and regulates the safety of animal
feeds, including pet food. http://www.fda.gov/cvm/default.html
• The National Center for Toxicological Research (NCTR), located in Arkansas,
conducts research on the biological effects of widely used chemicals. NCTR does
not have regulatory responsibilities. http://www.fda.gov/nctr/index.html
• The Office of Regulatory Affairs conducts FDA’s compliance activities,
including inspection and enforcement. http://www.fda.gov/ora/
’œ?˜›¢ȱŠ—?ȱŽ?’œ•Š?’ŸŽȱž?‘˜›’?’Žœȱ
Until the beginning of the 20th century, charlatans peddled adulterated and mislabeled medicines
throughout the United States without penalty. In 1902, Congress passed the Biologics Control Act
after 13 children died from a diphtheria vaccine contaminated with tetanus. In 1906, Congress
passed the Food and Drugs Act. These were the first in a series of laws intended to assure
Americans that the medicines they used did no harm and actually worked—that they are, in other
words, safe and effective.
Over the next 60 years, Congress passed two major pieces of legislation expanding FDA authority
in pursuit of those goals. It passed the Federal Food, Drug, and Cosmetic Act (FFDCA) in 1938,
which authorized FDA food-related activities and required that drugs be proven safe before they
could be sold in interstate commerce. Then, in 1962, in the wake of the thalidomide tragedy,
Congress amended the law to require that drugmakers prove the effectiveness of their products as
well.20 Since 1962, FDA’s authority and regulatory scope have continued to evolve.
As an agency, FDA and its predecessors have had several administrative homes in the federal
government. The box below tracks the highlights of its organizational moves.21
FDA Organizational Timeline
1862
New Bureau of Chemistry in the new U.S. Dept. of Agriculture (USDA)
1927
Bureau of Chemistry became the Food, Drug, and Insecticide Administration
1931
Renamed: the USDA Food and Drug Administration (FDA)
1940
FDA transferred from USDA to the Federal Security Agency (FSA)
1953
FSA became the Dept. of Health, Education, and Welfare (HEW)
1968
FDA (remaining in HEW) became part of the Public Health Service (PHS)

20 Kefauver-Harris Drug Amendments to the FFDCA, P.L.87-781 (1962).
21 See FDA and USDA Web pages at http://www.fda.gov/opacom/backgrounders/miles.html and
http://www.fsis.usda.gov/About_FSIS/Agency_History/index.asp.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗśȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
1980
HEW (without Education) became the Dept. of Health and Human Services (HHS)
The FFDCA is the principal source of FDA’s authority.22 The Act consists of the following
chapters, governing the majority of FDA’s activities:
FFDCA Chapters
Chapter I:
Short Title.
Chapter II:
Definitions.
Chapter III:
Prohibited Acts and Penalties.
Chapter IV:
Food. Pursuant to the definition in Section 201, food is defined to include foods for humans, as
well as animal feeds, including pet food.
Chapter V:
Drugs and Devices. Includes provisions regarding the regulation of human drugs and medical
devices, and animal drugs; certain provisions regarding biological products; and certain special
provisions such as those regarding pediatric drug studies.
Chapter VI:
Cosmetics.
Chapter VII:
General Authority. Includes, among other things, authority to promulgate regulations, and to
conduct inspections and investigations.23
Chapter VIII:
Imports and Exports.
Chapter IX:
Miscellaneous.
FDA is also responsible for certain provisions in other laws, most notably the Public Health
Service (PHS) Act.24 The PHS Act contains certain specific provisions that are implemented by
FDA, such as mammography quality standards.25 The Act also contains certain broad provisions
that are implemented by FDA. An example is FDA’s enforcement of a ban on the interstate sale of
baby turtles, which can cause Salmonella infections, as an exercise of the HHS Secretary’s broad
authority under the PHS Act to control diseases.26
FDA’s authority to regulate most human biologics—products such as vaccines, blood and blood
components—flows from provisions in the PHS Act (Section 351) and in specific sections of the
FFDCA.27 Furthermore, different types of biologics may be regulated by either CDER or
CBER.28 Veterinary biologics, such as animal vaccines, are not regulated by FDA. They fall under
a separate law, the Virus, Serum, and Toxin Act, which is administered by USDA.

22 The FFDCA is codified at 21 U.S.C. § 301 et seq. The FDA website offers the text of FFDCA chapters (current
through December 2004); a cross-reference to corresponding sections in Title 21, Chapter 9 of the U.S. Code; and
significant amendments to the FFDCA, at http://www.fda.gov/opacom/laws/.
23 In general, FDA’s regulations are found in Title 21 of the Code of Federal Regulations. FDA maintains a current
searchable version of Title 21 on its website at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm.
24 A listing of the many other laws containing provisions for which FDA is responsible is available at
http://www.fda.gov/opacom/laws/#other.
25 Public Health Service Act, Sec. 354, 42 U.S.C. § 263b.
26 Public Health Service Act, Sec. 361, 42 U.S.C. § 264.
27 See FDA, Center for Biologics Evaluation and Research, “Frequently Asked Questions,” at http://www.fda.gov/cber/
faq.htm.
28 See FDA, “Transfer of Therapeutic Biological Products to the Center for Drug Evaluation and Research,” at
http://www.fda.gov/oc/combination/transfer.html.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗŜȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
Budget. FDA has a total budget of nearly $2.3 billion for FY2008. Table 5 presents FDA funding
levels for FY2007 through FY2009. FDA’s budget has two funding streams: direct appropriations
(budget authority, or BA) and industry user fees. In FDA’s annual appropriation, Congress sets
both the total amount of appropriated funds and the level of user fees to be collected that year.
Appropriated funds are largely for salaries and expenses ($1.714 billion in FY2008), with a much
smaller amount for buildings and facilities ($6 million in FY2008). User fees ($549 million in
FY2008) come from several programs: the three major user fee programs provide support for
FDA’s prescription drug, medical device, and animal drug activities, whereas smaller amounts
come from mammography clinic certification fees and export and color certification fees. The
FY2008 total for FDA—the program level—was $2.270 billion, 15.0% above the FY2007 actual
level.
Although the FDA’s authorizing committees in Congress are the committees with jurisdiction
over public health issues—the Senate Committee on Health, Education, Labor, and Pensions, and
the House Committee on Energy and Commerce—FDA’s assignment within the appropriations
committees reflects its origin within the Department of Agriculture. The appropriations
subcommittees on Agriculture, Rural Development, FDA, and Related Agencies have jurisdiction
over FDA’s budget, even though the agency has been part of various federal health agencies
(HHS and its predecessors) since 1940.
For additional information on FDA, see CRS Report RL34334, The Food and Drug
Administration: Budget and Statutory History, FY1980-FY2007, coordinated by Judith A.
Johnson.
Table 5. Food and Drug Administration (FDA)
(dollars in millions)
FY2007
FY2008
FY2009
% change FY09
Program area
Funds actual
enacted
requesta
vs. FY08
Foods BA
457
510
543
6.4%
Human drugs
BA 315 353 358
1.3%
Fees 228 327
381
16.4%
Total 544
680
739
8.6%
Biologics
BA 146 155 158
1.9%
Fees 56
81
87
8.2%
Total 202
236
245
4.0%
Animal drugs and feeds
BA 95 97 104
6.7%
Fees 11
12
16
37.0%
Total 106
109
119
9.9%
Devices and radiological healthb
BA 231 238 242
1.6%
Fees 37
46
49
7.1%
Total 268
284
291
2.5%
Toxicological research (NCTR)
BA
42
44
46
4.1%
Headquarters and Office of the
BA 92 97
99
2.0%
Commissionerb
Fees 20
36
40
10.8%
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗŝȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
FY2007
FY2008
FY2009
Program area
Funds actual
enacted
request
% change FY09
a
vs. FY08
Total 111
133
139
4.3%
GSA rent
BA 127 131
131
0.0%
Fees 12
29
25
-11.4%
Total 139
159
156
-2.0%
Other rent and rent-related (including
BA 68
89
89
0.0%
White Oak consolidation)
Fees 18
10
20
92.9%
Total 86
99
109
9.8%
Export and color certification funds
Fees 10
10
10
8.4%

Subtotal, Salaries & Expenses
BA 1,572 1,714 1,769
3.2%
Fees 391
549
628
14.4%
Total 1,964
2,264
2,397
5.9%
Buildings & Facilities
BA
10
6
2
-60.5%
Total, FDA Budget Authority
BA
1,583
1,720
1,771
2.9%
Total, FDA User Fees
Fees
391
549
628
14.4%
Total, FDA Program Level
Total
1,974
2,270
2,400
5.7%
Source: Adapted by CRS from FDA, Justification of Estimates for Appropriations Committees, Fiscal Year 2009, at
http://www.fda.gov/oc/oms/ofm/budget/documentation.htm.
Notes: Totals and percentages may not compute exactly due to rounding. BA = budget authority, also referred
to as direct appropriations. Fees = collected user fees. Total program level = budget authority plus user fees.
a. The FY2009 request includes a total of $35.5 million in new or proposed user fees: Direct to Consumer
advertising ($14.0 million), proposed Generic Drug User Fee Act ($16.6 million), and proposed Animal
Generic Drug User Fee Act ($4.8 million).
b. Includes mammography user fees.
ŽŠ•?‘ȱŽœ˜ž›ŒŽœȱŠ—?ȱŽ›Ÿ’ŒŽœȱȱ
?–’—’œ?›Š?’˜—ȱǻ Ǽȱ
’œœ’˜—ȱ
The Health Resources and Services Administration (HRSA)—”the access agency”—provides
leadership and support for health services and resources for people who are uninsured, isolated, or
medically vulnerable. According to HRSA, its programs target, for example, the 47 million
Americans who lack health insurance, over 50 million Americans who live in rural and poor
urban areas where health care services are scarce, more than 1 million people living with
HIV/AIDS, and over 94,000 Americans who are waiting for an organ transplant.29

29 HRSA, Justification of Estimates for Appropriations Committees, Fiscal Year 2009, p. 3, available at
(continued...)
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗŞȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
HRSA funds projects to support health services through grants to community-based
organizations; colleges and universities; hospitals; state, local, and tribal governments;
associations; national groups; and foundations. These grantees provide various services that
include the identification of recruitment and training needs for the state and national health
workforce; recruitment and retention of qualified health professionals to serve in the primary care
workforce; administration of programs relating to implementation of state maternal and child
health service programs; development of integrated information systems to enhance quality of
and access to health services in underserved populations; and management of the federal response
to health care needs for persons living with HIV/AIDS. In addition, HRSA administers the
program for health centers, which provides grants for basic primary medical services to people
who live in rural and urban areas and experience financial, geographic, cultural, or other barriers
to health care.
›?Š—’£Š?’˜—ȱŠ—?ȱŽ¢ȱ›˜?›Š–œȱ
HRSA is headquartered in Rockville, MD, and is organized into six bureaus, 13 offices, and one
center. The agency, restructured several times between 2003 and 2007 by the Bush
Administration, currently has the following organizational components:
• The Bureau of Primary Health Care aims to increase access to primary and
preventive health care and improve the health status of underserved and
vulnerable populations. Its largest program, Health Centers, provides grants to
over 4,000 health centers and clinics that provide routine access to health care for
over 17 million people living in inner city and rural areas.
• The Bureau of Clinician Recruitment and Service administers programs
authorized under various titles of the PHS Act. In 2007, HHS announced creation
of the new Bureau of Clinician Recruitment and Service and transfer of the
following programs from the Bureau of Health Professions: National Health
Service Corps, Nursing Scholarship Program, Nursing Education Loan
Repayment Program, Faculty Loan Repayment Program, and the Native
Hawaiian Scholarship Program (which has not been funded in recent years).
These programs attract and recruit individuals from all backgrounds to study and
work in medicine, nursing, dentistry, mental and behavioral health services, and
other allied health fields.
• The Bureau of Health Professions aims to provide national leadership in the
development, distribution, and retention of a diverse, culturally competent health
workforce. Grants to institutions target education and training opportunities at all
academic levels, from elementary through post-graduate education. Individuals
who are specializing in primary care medicine and dentistry, geriatrics, and allied
health professions, among others, benefit from these grants. Many of these
programs are authorized in Title VII, Health Professions Education and Title
VIII, Nursing Workforce Development.
• The Maternal and Child Health Bureau seeks to strengthen the infrastructure
for maternal and child health services. The Maternal and Child Health Block

(...continued)
ftp://ftp.hrsa.gov/about/budgetjustification09.pdf#page=10.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŗşȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
Grant, Healthy Start, and Emergency Medical Services for Children, offered by
state and local health agencies, are among its larger programs.
• The HIV/AIDS Bureau administers programs consolidated by the Ryan White
HIV/AIDS Treatment Modernization Act.30 The programs provide life-saving and
life-extending services for people living with HIV/AIDS. According to HRSA,
these programs reach more than 500,000 individuals throughout the country each
year, making it the federal government’s largest discretionary grant program for
people living with HIV/AIDS.
• The Healthcare Systems Bureau provides leadership and direction in the
development of national programs and services for health emergency
preparedness, vaccine injury compensation, bone marrow transplantation, organ
transplantation and procurement, and poison control centers, among other
functions.
Among HRSA’s 13 offices, some focus on specific populations or health care issues, while others
are involved with the agency’s management. The Office of Rural Health Policy (ORHP) is
significant in its mission to promote access to health care services in rural populations. ORHP is
responsible for informing and advising the Secretary of HHS on matters affecting rural health
care. Other offices address issues related to minority health and health disparities, international
health, health information technology, federal assistance management, financial management,
legislation, communications, and performance review, among other things. A new Center for
Quality coordinates activities related to strengthening and improving the quality of health care in
HRSA programs and on behalf of its service populations.31
’œ?˜›¢ȱŠ—?ȱŽ?’œ•Š?’ŸŽȱž?‘˜›’?’Žœȱ
In 1935, Congress authorized the first programs for maternal and child health services and
general health grants to states in various sections of the Social Security Act. Around 1940, these
programs were transferred to the newly created Federal Security Agency (FSA) and later
administered in the Bureau of Medical Services and Bureau of State Services. In 1953, the
Department of Health, Education and Welfare (HEW) was created at cabinet level and replaced
the FSA. Federal support for health services continued to evolve in HEW, and new targets for
service focused on migrant health, health workforce development, and hospital and health facility
construction. Within HEW, two new agencies, the Health Services Administration and the Health
Resources Administration, were created in 1973. In 1982, the Secretary of HHS merged the two
agencies into the present-day HRSA.
Currently, HRSA supports a variety of programs established under various authorities. Although
the majority of programs are authorized in the PHS Act, a few are authorized in the Social
Security Act. For example, in the PHS Act, Title III authorizes the Community Health Centers
Program, National Health Service Corps, Children’s Hospitals Graduate Medical Education
Program, Organ Transplant and Bone Marrow Programs, Telehealth Program, and State Offices of
Rural Health. Title VII authorizes programs for health workforce development, and Title VIII
authorizes programs for nursing workforce development. Title XXVI consolidates all Ryan White

30 P.L. 109-415 was signed on December 19, 2006.
31 See more information at HRSA’s website, at http://www.hrsa.gov/about/default.htm.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŘŖȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
HIV/AIDS programs. Various sections of the Social Security Act authorize Maternal and Child
Health Block Grants and the Rural Health Policy Development Programs. Finally, Section 427(e)
of the Federal Mine Safety and Health Amendments Act (P.L. 95-164) authorizes the Black Lung
Program, which supports clinics that provide services to retired coal miners and others.
Table 6 presents funding levels for HRSA programs for FY2007 through FY2009. For detailed
appropriations on programs in Title VII and Title VIII, see CRS Report RS22438, Health
Professions Programs in Title VII and Title VIII of the Public Health Service (PHS) Act:
Appropriations History (FY2002-FY2009), by Bernice Reyes-Akinbileje and Mary Vennetta
Wright.
Table 6. Health Resources and Services Administration (HRSA)
(dollars in millions)
FY2007
FY2008
FY2009Pres.
% change
Bureaus, Offices, and Programs
actual
enacted
request
FY09 vs. FY08
Health Centers
1,988
2,065
2,092
1.3%
Other BPHC Programs
18
18
18
2.1%
Subtotal, Bureau of Primary Health
Care (BPHC)
2,006 2,083 2,110
1.3%
National Health Service Corps
126
123
121
-2.0%
Loan Repayment/Fellowships (Sec. 738)a 1 1
0 -100%
Nursing Scholarships/Loan Repayment (Sec.
846)b
31 31 44 41.9%
Subtotal, Bureau of Clinician
Recruitment and Service (BCRS)
158 155 165 6.1%
Health Professionsa
183 193
0
-100.0%
Nursing Workforce Developmentb 119
126 66 -47.3%
Children’s Hospitals Graduate Medical
Education
297 302
0
-100.0%
Pt. Navigator Outreach/Chronic Disease
Prevent
0 3 0 -100.0%
Subtotal, Bureau of Health Professions
(BHPr)
599 623
66
-89.4%
Maternal and Child Health Block Grant
693
666
666
0.0%
Healthy Start
102
100
100
0.0%
Other MCHB Programs
41
79
39
-51.2%
Subtotal, Maternal and Child Health Bureau
(MCHB)c
835 845 804 -4.8%
Subtotal, HIV/AIDS Bureaud 2,113
2,142
2,143
0.1%
Subtotal, Healthcare Systems Bureau
75
82
68
-16.9%
Subtotal, Rural Health Programs
168
175
25
-85.9%
Health Care-Related Facilities and Activities
0
304
0
-100.0%
Parklawn Building Lease Replacement
0
0
36
na
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
Řŗȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
FY2007
FY2008
FY2009Pres.
% change
Bureaus, Offices, and Programs
actual
enacted
request
FY09 vs. FY08
Telehealth + Program Management
153
148
148
0.1%
Family Planning
283
300
300
0.0%
Subtotal, Other HRSA Programs
436
752
484
-35.7%
Total, Health Resources and Services
account, discretionary
6,391 6,856 5,865 -14.5%
Health Education Assistance Loans (HEAL)
3
3
3
2.1%
Vaccine Injury Compensation Program direct
operations
4 5 5 -16.2%
Total, HRSA discretionary budget
authority
6,398 6,864
5,872
-14.5%
National Practitioner Data Bank (User
Fees)e
16 19 19 1.8%
Health Care Integrity and Protection Data
Bank (User Fees)e
4 4 0 -100.0%
Family to Family Health Information Centers
(mandatory)f
3 4 5 25.0%
PHS Evaluation Tap fundingg 25
25
25
0.0%
HEAL Liquidating Account
1
1
1
0.0%
Total, HRSA program level
6,447
6,917
5,922
-14.4%
Source: Adapted by CRS from HRSA, Justification of Estimates for Appropriations Committees, FY2009, All-Purpose
Table, p. 7, at ftp://ftp.hrsa.gov/about/budgetjustification09.pdf#page=14.
Notes: Totals and percentages may not compute exactly due to rounding.
a. Total appropriations for Title VII programs are obtained by adding the appropriation for Sec. 738,
administered by the BCRS, to the appropriations for the various health professions programs administered
by the BHPr. Total appropriations for Title VII programs are as follows: FY2007, $185 million; FY2008, $194
million; and FY2009 request, $0.
b. Total appropriations for Title VIII programs are obtained by adding the appropriation for Sec. 846,
administered by the BCRS, to the appropriations for the various nursing workforce development programs
administered by the BHPr. Total appropriations for Title VIII programs are as follows: FY2007, $150 million;
FY2008, $156 million; and FY2009 request, $110 million.
c. Excludes mandatory funding for Family to Family Health Information Centers.
d. Excludes the amount for PHS Evaluation Tap funding ($25 million).
e. User fees available for Bureau of Health Professions.
f. Mandatory funds for Maternal and Child Health Bureau appropriated in the Deficit Reduction Act of 2005
(P.L. 109-171).
g. Additional funds for Ryan White AIDS programs from PHS Evaluation Set-Aside (§ 241 of PHS Act).
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŘŘȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
—?’Š—ȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ
’œœ’˜—ȱ
The Indian Health Service (IHS) provides, or funds the provision of, direct health care services to
members of the nation’s 562 federally recognized Indian32 tribes (totaling about 1.8 million
Indians in 35 states) who are in IHS service delivery areas.33 Services are provided through IHS-
funded clinics, hospitals, health centers, and other facilities, operated by IHS itself, Indian tribes,
tribal organizations, or urban Indian organizations. Health care services are also provided through
contracts with private health services providers. Besides services, IHS also funds the
construction, equipping, operation, and maintenance of health care and sanitation facilities.
IHS health care services cover almost the entire range of clinical health services, including
ambulatory, inpatient, preventive, mental health, and dental care. IHS’s public health services
include home and community sanitation facilities, public health nurses, and epidemiology.
Besides providing general clinical health services, IHS also focuses on special Indian health
problems, such as fetal alcohol syndrome, diabetes prevention and treatment, alcoholism and
mental health, hepatitis B, and maternal and child health.
Eligible Indians receive free IHS health services regardless of their ability to pay. The federal
government considers its provision of these health services to be based on its trust responsibility
for Indian tribes, a responsibility derived from federal statutes, treaties, court decisions, executive
actions, and the Constitution (which assigns authority over Indian relations to Congress). IHS
programs are not entitlement programs, but rather are funded through discretionary
appropriations, plus reimbursements from third parties, including Medicare and Medicaid.
Available funding is not sufficient to cover all Indian health services needs, however, so IHS does
not provide the same health care services in all areas. Services vary from place to place and from
time to time.
›?Š—’£Š?’˜—ȱŠ—?ȱŽ¢ȱ›˜?›Š–œȱ
To carry out its roles for health care services and health care facilities, the IHS is organized into a
headquarters office, 12 regions (each directed by an area office), and 163 service units (each
assigned to an area office).34 At the headquarters level, and within area offices and service units
where relevant, there are programmatic offices for the following activities:
• clinical and preventive health services, including clinical and community
services, behavioral health, nursing services, oral health, and diabetes treatment
and prevention;

32 In this report, the term “Indian” means American Indians and Alaska Natives. The latter term includes the Eskimos
(Inuit and Yupik), Aleuts, and American Indians of Alaska.
33 IHS also funds limited health services to Indians in certain urban areas.
34 A service unit is an administrative entity within a defined geographical area, through which services are directly or
indirectly provided to eligible Indians. A service unit may cover a number of small reservations, or, conversely, a large
reservation may be covered by several service units.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
Řřȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
• public health support, including disease prevention and epidemiology, and health
professions recruitment and scholarship programs; and
• environmental health and engineering, including health facilities planning and
construction, sanitation facilities construction, facilities operation, engineering,
and environmental health services.
Direct clinical health care is provided through 46 inpatient hospitals and 633 ambulatory facilities
(which include 304 health clinics, 143 health stations, 166 Alaska village clinics, and 20 school
health centers). Fifteen of the hospitals and 550 of the ambulatory facilities are operated by tribes
and tribal organizations, under contracts and compacts pursuant to the Indian Self-Determination
and Education Assistance Act of 1975.35 The remaining facilities are operated by the IHS. In
addition, IHS funds 34 urban Indian health projects in 41 urban sites through federal contracts
and grants.36
The IHS offers information on its programs through its website at http://www.ihs.gov.
’œ?˜›¢ȱŠ—?ȱŽ?’œ•Š?’ŸŽȱž?‘˜›’?’Žœȱ
Health care services for Indians developed gradually over the course of the 19th century, pursuant
to congressional appropriations but without an explicit statutory establishment of an Indian
medical agency. What health services were provided were under the War Department before
1849, and under the Department of the Interior after 1849, when the Bureau of Indian Affairs
(BIA) was transferred to Interior. While the number of BIA hospitals and physicians gradually
increased in the late 19th and early 20th centuries, BIA did not have a bureau-wide medical
supervisor until 1908. The Snyder Act of 192137 authorized federal programs for Indians within
the BIA, including health care, but did not establish an Indian medical agency. In 1954, Congress
passed the Transfer Act, directing that Interior’s and the BIA’s responsibilities, functions, and
facilities for Indian health care be transferred to the Surgeon General of the Public Health Service
in the Department of Health, Education, and Welfare.38 The transfer occurred on July 1, 1955, and
since then, IHS has been a part of the PHS.
Besides general statutory authority under the Snyder Act and the Transfer Act, specific IHS
programs are authorized by the Indian Sanitation Facilities Act of 1959,39 authorizing the PHS to
construct sanitation facilities for Indian communities and homes; the Indian Health Care
Improvement Act (IHCIA) of 1976,40 which established many specific IHS programs, such as
urban health, professions recruitment, and mental health, and which also amended the Social
Security Act to authorize IHS to make direct collections from Medicare/Medicaid and third-party
insurers; and the Indian Self-Determination and Education Assistance Act of 1975,41 which

35 P.L. 93-638, act of January 4, 1975, 88 Stat. 2203, as amended; 25 U.S.C. § 450 et seq.
36 Statistics in this paragraph are from U.S. Department of Health and Human Services, Indian Health Service,
Justification of Estimates for Appropriations Committees, Fiscal Year 2009, pp. CJ-123 and CJ-218.
37 Act of November 2, 1921, 42 Stat. 208, as amended; 25 U.S.C. § 13.
38 P.L.83-568, act of August 5, 1954, 68 Stat. 674, as amended; 42 U.S.C. § 2001 et seq.
39 P.L.86-121, act of July 31, 1959, 73 Stat. 267; 42 U.S.C. § 2004a.
40 P.L. 94-437, act of September 30, 1976, 90 Stat. 1400, as amended; 25 U.S.C. § 1601 et seq., and 42 U.S.C. §
1395qq, § 1396j (and amending other sections).
41 P.L. 93-638, act of January 4, 1975, 88 Stat. 2203, as amended; 25 U.S.C. § 450 et seq.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŘŚȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
provides for tribal administration of federal Indian programs, especially BIA and IHS programs,
under self-determination contracts and self-governance compacts.
Unlike most other PHS agencies, the IHS receives its appropriations under the Interior,
Environment, and Related Agencies Appropriations Act, not under the Labor-HHS-Education
Appropriations Act.
The Snyder Act, as it currently stands, can be considered a permanent, general authorization for
IHS. The IHCIA’s authorizations of appropriations, however, which are more program-specific,
expired at the end of FY2001. Congress continues to appropriate funds for IHS and has been
considering IHCIA reauthorization bills since the 106th Congress. In the 110th Congress, the
Senate’s IHCIA reauthorization bill (S. 1200) was passed by the Senate on February 26, 2008,
and forwarded to the House, while the House bill (H.R. 1328) has been ordered reported from one
committee and must be considered by two other committees of jurisdiction.
Table 7 presents funding levels for IHS programs for FY2007 through FY2009. For further
information on IHS, see CRS Report RL33022, Indian Health Service: Health Care Delivery,
Status, Funding, and Legislative Issues, by Roger Walke.
Table 7. Indian Health Service (IHS)
(dollars in millions)
FY2007
FY2008
FY2009 Pres.
% change FY09
Programs
actual
enacted
request
vs. FY08
Health Services
Clinical Services
Hospitals and Health Clinics
1,411
1,484
1,522
2.6%
Dental Health
125
134
138
3.2%
Mental Health
61
64
66
3.6%
Alcohol and Substance Abuse
148
173
162
-6.5%
Contract Health Care
543
553
563
1.9%
Catastrophic Health Emergency Fund N/A
27
25
-6.0%
Subtotal, Clinical Services
2,289
2,434
2,476
1.7%
Preventive Health
Public Health Nursing
52
56
58
4.2%
Health Education
14
15
25
1.6%
Community Health Reps.
55
55
56
1.6%
Immunization (Alaska)
2
2
2
1.6%
Subtotal, Preventive Health
123
128
131
2.7%
Other Health Services
Urban Health Projects
34
35
0
-100.0%
Indian Health Professions
31
36
22
-39.7%
Tribal Management
2
2
3
1.6%
Direct Operations
64
64
63
-1.6%
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
Řśȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
FY2007
FY2008
FY2009 Pres.
% change FY09
Programs
actual
enacted
request
vs. FY08
Self-Governance 6
6
6
1.6%
Contract Support Costs
270
267
272
1.6%
Subtotal, Other Health Services
407
410
365
-11.1%
Subtotal, Health Services
2,819
2,972
2,972
0.0%
Health Facilities
Maintenance and Improvement
55
53
53
0.0%
Sanitation Facilities Construction
94 94 94
0.0%
Health Care Facilities Construction
26
37
16
-56.8%
Facilities/Environmental Health
165 170 169
-0.3%
Support
Equipment 22
21
21
0.0%
Subtotal, Health Facilities
361
375
353
-5.7%
Total, IHS discretionary budget
authority
3,180 3,346 3,325
-0.6%
Collections 773
786
786
0.0%
Special Diabetes Program for Indiansa 150
150
150
0.0%
Total, IHS program level
4,103
4,282
4,261
-0.5%
Source: Adapted by CRS from IHS, Justification of Estimates for Appropriations Committees, Fiscal Year 2009, All-
Purpose Table, p. CJ-3, at http://www.ihs.gov/NonMedicalPrograms/BudgetFormulation/
bf_cong_justifications.asp.
Note: Totals and percentages may not compute exactly due to rounding.
a. Funds available to IHS for Special Diabetes Program for Indians (P.L. 105-33, P.L. 106-554, P.L.
107-360, and P.L. 110-173; 42 U.S.C. 254c-3).
Š?’˜—Š•ȱ —œ?’?ž?Žœȱ˜?ȱ ŽŠ•?‘ȱǻ Ǽȱ
’œœ’˜—ȱ
The National Institutes of Health is the primary agency of the federal government charged with
conducting and supporting biomedical and behavioral research. It also has major roles in research
training and health information dissemination. According to the NIH website, “Its mission is
science in pursuit of fundamental knowledge about the nature and behavior of living systems and
the application of that knowledge to extend healthy life and reduce the burdens of illness and
disability.”42
NIH is the largest of the PHS agencies, with a budget of $29.2 billion in FY2008 (see Table 9)
and total employment of more than 18,000 people. Over 80% of NIH’s annual funding goes out
through grant, contract, and training awards to extramural scientists working in universities,

42 See http://www.nih.gov/about/.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŘŜȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
academic health centers, hospitals, and independent research institutions in the United States and
abroad. The NIH intramural research program, accounting for about 10% of the budget, includes
more than 6,500 scientists and technical support staff who are government employees, and
several thousand additional scientific fellows, guest researchers, and contractors. The remainder
of the budget is for research management, administration, and physical infrastructure.
›?Š—’£Š?’˜—ȱŠ—?ȱŽ¢ȱ›˜?›Š–œȱ
The agency’s organization consists of the Office of the NIH Director and 27 institutes and
centers. The Office of the Director (OD) sets overall policy for NIH and coordinates the programs
and activities of all NIH components, particularly trans-institute research initiatives and issues.
The individual institutes and centers (ICs), each of which focuses on particular diseases, areas of
human health and development, or aspects of research support, plan and manage their own
research programs in coordination with the Office of the Director. As shown in Table 9, Congress
provides separate appropriations to 24 of the 27 ICs, to OD, and to a buildings and facilities
account. (The remaining three centers, not included in the table, are funded through the NIH
Management Fund, financed by taps on other NIH appropriations.) NIH occupies a 317-acre main
campus in Bethesda, MD, as well as numerous off-campus sites, including locations in Maryland,
North Carolina, and Montana.
The institutes and centers, listed in the order found in appropriations acts, are briefly described
below.43 Each leads a national research and information program in the research areas indicated.
• Office of the Director (OD) has charge of overall NIH leadership, and liaison
with HHS. It includes special offices for research on AIDS, women’s health,
behavioral and social sciences, and disease prevention (including rare diseases
and dietary supplements).
• National Cancer Institute (NCI, established 1937). All aspects of cancer—
cause, diagnosis, prevention, treatment, rehabilitation, and continuing care of
patients.
• National Heart, Lung, and Blood Institute (NHLBI, established 1948).
Diseases of the heart, blood vessels, lungs, and blood; sleep disorders; and blood
resources management. It also administers the NIH Woman’s Health Initiative.
• National Institute of Dental and Craniofacial Research (NIDCR, established
1948). Infectious and inherited oral, dental, and craniofacial diseases and
disorders.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK,
established 1948). Diabetes, endocrinology, metabolic diseases; digestive
diseases and nutrition; and kidney, urologic, and hematologic diseases.
• National Institute of Neurological Disorders and Stroke (NINDS, established
1950). Convulsive, neuromuscular, demyelinating, and dementing disorders;
fundamental neurosciences; stroke, trauma.

43 For further information on each component, see http://www.nih.gov/icd/. See also the NIH Almanac, 2006-2007, at
http://www.nih.gov/about/almanac/about.htm.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
Řŝȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
• National Institute of Allergy and Infectious Diseases (NIAID, established
1948). Infectious, immunologic, and allergic diseases.
• National Institute of General Medical Sciences (NIGMS, established 1962).
Research and research training in basic biomedical sciences (cellular and
molecular biology, genetics, pharmacology, physiology). Special focus on
minority researchers.
• National Institute of Child Health and Human Development (NICHD,
established 1962). Reproductive biology; population issues; embryonic
development; maternal, child, and family health; medical rehabilitation.
• National Eye Institute (NEI, established 1968). Eye diseases, visual disorders,
visual function, preservation of sight, health problems of the visually impaired.
• National Institute of Environmental Health Sciences (NIEHS, established
1969). Interrelationships of environmental factors, individual genetic
susceptibility, and age as they affect health.
• National Institute on Aging (NIA, established 1974). Biomedical, social, and
behavioral research on the aging process; diseases, problems, and needs of the
aged.
• National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS, established 1986). Arthritis; bone, joint, connective tissue and muscle
disorders; skin diseases.
• National Institute on Deafness and Other Communication Disorders
(NIDCD, established 1988). Normal mechanisms and disorders of hearing,
balance, smell, taste, voice, speech, and language.
• National Institute of Nursing Research (NINR, established 1986).
Management of acute and chronic illness, health promotion/disease prevention,
nursing systems, clinical therapeutics.
• National Institute on Alcohol Abuse and Alcoholism (NIAAA, established
1970). Causes of alcoholism, how alcohol damages the body, prevention and
treatment strategies.
• National Institute on Drug Abuse (NIDA, established 1973). Social, biological,
behavioral, and neuro-scientific bases of drug abuse and addiction; causes,
prevention, and treatment strategies.
• National Institute of Mental Health (NIMH, established 1949). Brain research,
mental illness, and mental health.
• National Human Genome Research Institute (NHGRI, established 1989).
Chromosome mapping, DNA sequencing, database development,
ethical/legal/social implications of genetics research.
• National Institute of Biomedical Imaging and Bioengineering (NIBIB,
established 2000). Research, training and coordination in biomedical imaging,
bioengineering and related technologies and modalities, including biomaterials
and informatics.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
ŘŞȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
• National Center for Research Resources (NCRR, established 1962).
Extramural and intramural research resources and technologies, including general
clinical research centers, computers, instrument systems, animal resources and
facilities, and nonmammalian research models.
• National Center for Complementary and Alternative Medicine (NCCAM,
established 1999). Identifies, evaluates, and researches unconventional health
care practices.
• National Center on Minority Health and Health Disparities (NCMHD,
established 1993). Research, training, and coordination on minority health
conditions and populations with health disparities.
• John E. Fogarty International Center (FIC, established 1968). Focal point for
NIH’s international collaboration activities and scientific exchanges; provides
leadership in global health.
• National Library of Medicine (NLM, established 1956). Collects, organizes,
and makes available biomedical information; sponsors programs to improve
biomedical communications and U.S. medical library services.
• NIH Clinical Center (CC, established 1953). NIH’s hospital and outpatient
facility for clinical research.
• Center for Scientific Review (CSR, established 1946). Receives, assigns, and
reviews research and training grant applications.
• Center for Information Technology (CIT, established 1964). Provides,
coordinates, and manages information technology for NIH; research to advance
computational science.
’œ?˜›¢ȱŠ—?ȱŽ?’œ•Š?’ŸŽȱž?‘˜›’?’Žœȱ
NIH traces its roots to 1887, when a one-room Laboratory of Hygiene was established at the
Marine Hospital in Staten Island, New York. Relocated to Washington, DC, in 1891, and renamed
the Hygienic Laboratory, it operated for its first half century as an intramural research lab for the
Public Health Service. Congress designated the lab the National Institute of Health in 1930 (P.L.
71-251). It moved to donated land in the Maryland suburbs in 1938. By 1948, several new
institutes and divisions had been created, and the agency became the National Institutes of Health
(P.L. 80-655). As indicated in the list above, Congress continued to add new institutes and centers
for several decades, most recently in 2000.
Section 301 of the Public Health Service Act (42 U.S.C. § 241) grants the Secretary of HHS
broad permanent authority to conduct and sponsor research. In addition, Title IV, “National
Research Institutes” (42 U.S.C. § 281-290b), authorizes in greater detail various activities,
functions, and responsibilities of the NIH Director and the institutes and centers. All of the
institutes and centers are covered by specific provisions in the PHS Act. Prior to passage of the
NIH Reform Act of 2006 (P.L. 109-482), nine of the ICs and a variety of individual programs had
time-and-dollar limits on their authorizations of appropriations. Most of the authorizations had
expired, but § 301 provided authority for the programs. The other institutes and centers and most
NIH programs did not require periodic reauthorization by Congress, and there was no overall
authorization for the agency. The NIH Reform Act added a number of authorities for the NIH
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
Řşȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
Director, authorized total funding levels for NIH appropriations for FY2007 to FY2009, and
eliminated all of the other specific authorizations in Title IV.
For additional information on NIH, see CRS Report RL33695, The National Institutes of Health
(NIH): Organization, Funding, and Congressional Issues, by Pamela W. Smith, and the NIH
section of CRS Report RL34048, Federal Research and Development Funding: FY2008, by John
F. Sargent Jr. et al.
Table 8. National Institutes of Health (NIH)
(dollars in millions)
FY2007
FY2008
FY2009 Pres.
% change FY09
Institutes and Centers (ICs)
actuala
enactedb
request
vs. FY08
Cancer (NCI)
4,795
4,805
4,810
0.1%
Heart/Lung/Blood (NHLBI)
2,919
2,922
2,925
0.1%
Dental/Craniofacial Research (NIDCR) 390
390
391
0.1%
Diabetes/Digestive/Kidney (NIDDK)
1,706
1,707
1,708
0.1%
Neurological Disorders/Stroke
(NINDS)
1,535 1,544 1,545
0.1%
Allergy/Infectious Diseases (NIAID)c,d 4,366
4,561
4,569
0.2%
General Medical Sciences (NIGMS)
1,936
1,936
1,938
0.1%
Child Health/Human Development
(NICHD)
1,254 1,255 1,256
0.1%
Eye (NEI)
667
667
668
0.1%
Environmental Health Sciences (NIEHS) 642
642
643
0.1%
Aging (NIA)
1,047
1,047
1,048
0.1%
Arthritis/Musculoskeletal/Skin (NIAMS) 508
509
509
0.1%
Deafness/Communication Disorders
(NIDCD)
394 394 395
0.2%
Nursing Research (NINR)
137
137
138
0.1%
Alcohol Abuse/Alcoholism (NIAAA)
436
436
437
0.1%
Drug Abuse (NIDA)
1,000
1,001
1,002
0.1%
Mental Health (NIMH)e 1,404
1,405
1,407
0.1%
Human Genome Research (NHGRI)
486
487
488
0.2%
Biomedical Imaging/Bioengineering
(NIBIB)
298 299 300
0.5%
Research Resources (NCRR)
1,144
1,149
1,160
1.0%
Complementary/Alternative Med
(NCCAM)
121 122 122
0.1%
Minority Health/Health Disparities
(NCMHD)
199 200 200
0.1%
Fogarty International Center (FIC)
66
67
67
0.1%
Library of Medicine (NLM)
320
321
323
0.8%
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
řŖȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
FY2007
FY2008
FY2009 Pres.
% change FY09
Institutes and Centers (ICs)
actuala
enactedb
request
vs. FY08
Office of Director (OD)d 1,047
1,109
1,057
-4.7%
Common Fund (non-add)
(483)
(496)
(534)
7.7%
Buildings & Facilities (B&F)
81
119
126
5.6%
Subtotal, Labor/HHS
Appropriation
28,899 29,230
29,230
0.0%
Superfund (Interior approp to NIEHS)f
79 78 78
0.0%
Total, NIH discretionary budget
authority
28,978 29,307 29,307
0.0%
Pre-appropriated Type 1 diabetes fundsg 150 150 150
0.0%
PHS Evaluation Tap fundingh 8 8 8
0.0%
Global Fund transfer (AIDS/TB/Malaria)c -99
-295
-300
1.8%
Total, NIH program level
29,038
29,171
29,165
0.0%
Source: Adapted by CRS from NIH, Justification of Estimates for Appropriations Committees, Fiscal Year 2009,
Tabular Data, p. TD-1, at http://officeofbudget.od.nih.gov/UI/2008/tabular%20data.pdf.
Note: Totals and percentages may not compute exactly due to rounding.
a. FY2007 reflects the transfer of $99 million from NIH to the Office of the Secretary, as mandated by the
FY2007 supplemental appropriations act, P.L. 110-28 (see note d). FY2007 also reflects comparative
transfers to HHS ($0.542m) and among NIH ICs.
b. The FY2008 program level is an increase of $133 million (0.5%) over FY2007. FY2008 includes comparative
IC transfers from NHLBI to NIDDK ($0.816 million) and from NLM to NIDCR ($0.455 million).
c. NIAID totals include funds for transfer to the Global Fund to Fight HIV/AIDS, TB, and Malaria.
d. For FY2007, the war/emergency supplemental appropriations act (P.L. 110-28, May 25, 2007) transferred
funding for the Advanced Development of Medical Countermeasures to the Assistant Secretary for
Preparedness and Response ($49.5m from NIAID and $49.5m from OD).
e. FY2008 amount reflects transfer of $0.983 million from Office of the Secretary to NIMH to administer the
Interagency Autism Coordinating Committee.
f. Separate account in the Interior/Environment/Related Agencies appropriation for NIEHS research activities
related to Superfund.
g. Funds available to NIDDK for diabetes research under PHS Act § 330B (authorized by P.L. 106-554, P.L.
107-360, and P.L. 110-173).
h. Additional funds for NLM from PHS Evaluation Set-Aside (§ 241 of PHS Act).
ž‹œ?Š—ŒŽȱ‹žœŽȱŠ—?ȱŽ—?Š•ȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽœȱ
?–’—’œ?›Š?’˜—ȱǻ Ǽȱ
’œœ’˜—ȱ
SAMHSA supports states’ efforts to enhance prevention and treatment programs for substance
abuse and mental health disorders. SAMHSA provides federal support for these services by
administering two block grants (one for substance abuse prevention and treatment services, the
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
řŗȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
other for mental health services), two other formula grants, and discretionary grants to local
communities, states, and private entities to address the public health issues of substance abuse and
mental illness. SAMHSA funds a wide range of activities, including strategic planning, education
and training, prevention programs, early intervention, and treatment services.
In April 2006, SAMHSA published a matrix of the priority mental health and substance abuse
issues addressed by the agency, along with the agency’s cross-cutting principles.44 The priority
issue areas include individual health concerns such as co-occurring mental health and substance
abuse disorders, suicide, and behavioral health issues for individuals with hepatitis and
HIV/AIDS; societal issues such as homelessness and criminal justice; and systems-level issues
such as treatment capacity and workforce development. In addition, SAMHSA has identified
principles to guide program, policy, and resource allocation within the agency. These principles
include use of evidence-based practices, evaluation, collaboration, cultural competence, stigma
reduction, and cost-effectiveness.
›?Š—’£Š?’˜—ȱŠ—?ȱŽ¢ȱ›˜?›Š–œȱ
For FY2008, SAMHSA has a total budget of nearly $3.4 billion and a staff of approximately
534.45 For a breakdown of the agency’s budget, see Table 9. SAMHSA is composed of three
centers of operation, as described below. Each center has a director who reports to SAMHSA’s
Administrator. Each center has general authority to fund states and communities to address
priority substance abuse and mental health needs. This authority, called Programs of Regional and
National Significance (PRNS), authorizes SAMHSA to fund projects that (1) translate promising
new research findings into community-based prevention and treatment services, (2) provide
training and technical assistance, and (3) target resources to increase service capacity where it is
most needed. SAMHSA determines its funding priorities in consultation with states and other
stakeholders. SAMHSA offers information on its programs through its website at
http://www.samhsa.gov.
SAMHSA centers are as follows:
• Center for Mental Health Services (CMHS).46 CMHS supports mental health
services provided by the states and local governments through its mental health
block grant and discretionary grant programs. CMHS is authorized to prevent
mental illness and promote mental health by providing funds to evaluate,
improve, and implement effective treatment practices, address violence among
children, provide technical assistance to state and local mental health agencies,
and collect data.
• Center for Substance Abuse Prevention (CSAP).47 CSAP aims to improve the
quality of substance abuse prevention practices nationwide. Through its
discretionary grant programs, CSAP provides states, communities, organizations,

44
SAMHSA, Matrix of Priorities, April 2006, at http://www.samhsa.gov/Matrix/Matrix_Brochure_2006.pdf.
45 SAMHSA, Justification of Estimates for Appropriations Committees, Fiscal Year 2009, available at
http://www.samhsa.gov/Budget/FY2009/SAMHSA_CJ2009.pdf.
46 See http://mentalhealth.samhsa.gov/cmhs/.
47 See http://prevention.samhsa.gov/.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
řŘȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
and families with tools to promote protective factors and to reduce risk factors
for substance abuse. CSAP also supports the National Clearinghouse for Alcohol
and Drug Information (NCADI), the largest federal source of information about
substance abuse research, treatment, and prevention available to the public.
• Center for Substance Abuse Treatment (CSAT).48 CSAT aims to promote the
quality and availability of community-based substance abuse treatment services
for individuals and families who need them. CSAT works with states and
community-based groups to improve and expand existing substance abuse
treatment services under the formula-based substance abuse prevention and
treatment block grant. CSAT also supports SAMHSA’s free treatment referral
service to link people with the community-based substance abuse services they
need.
’œ?˜›¢ȱŠ—?ȱŽ?’œ•Š?’ŸŽȱž?‘˜›’?’Žœȱ
SAMHSA’s predecessor agency, the Alcohol, Drug Abuse and Mental Health Administration
(ADAMHA), was established in 1974. In 1992, Congress passed the ADAMHA Reorganization
Act (P.L. 102-321), which, among other things, established SAMHSA as a services agency with
programs focused on people with or at risk for mental or substance abuse disorders. The Act also
moved the three research institutes—National Institute of Mental Health (NIMH), National
Institute on Drug Abuse (NIDA), and National Institute on Alcohol Abuse and Alcoholism
(NIAAA)—to NIH, and renamed ADAMHA as SAMHSA to reflect its focus on funding
community-based services.
SAMHSA is authorized under Title V of the PHS Act, as amended (42 U.S.C. § 290aa—290kk-
3). In PHS Act Title XIX, SAMHSA’s block grants are authorized under Part B (42 U.S.C. §
300x-1—300x-66) and some additional programs are authorized under Part C (42 U.S.C. §
300y—300y-11). SAMHSA was last reauthorized in 2000, as part of the Children’s Health Act.49
At the time of that reauthorization, most of the agency’s programs were extended for three years,
through FY2003, and the block grant funding formula was not modified. The 2000
reauthorization focused on improving mental health and substance abuse services for children and
adolescents, implementing proposals to give states more flexibility in the use of block grant
funds, and replacing some existing categorical grant programs with general authority to give the
Secretary of HHS more flexibility to respond to those who require mental health and substance
abuse services.
Currently, authorizations for all of SAMHSA programs have expired. For additional information
on SAMHSA, see CRS Report RL33997, Substance Abuse and Mental Health Services
Administration (SAMHSA): Reauthorization Issues, by Ramya Sundararaman.

48 See http://csat.samhsa.gov/.
49 P.L. 106-310, Titles XXXI-XXXIV.
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
řřȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
Table 9. Substance Abuse and Mental Health Services Administration (SAMHSA)
(dollars in millions)
FY2007
FY2008
FY2009 Pres. % change FY09
Centers
actual
enacted
request
vs. FY08
Center for Mental Health Services (CMHS)
Programs of Regional and National Significance 263
299
155
-48.1%
Mental Health Block Grant
407
400
400
0.0%
PHS Evaluation Tap funding (non-add)a (21)
(21) (21) 0.0%
Mental Health Block Grant, program level (non-
add) (428)
(421)
(421)
0.0%
Children’s Mental Health
104
102
114
12.0%
Projects for Assistance in Transition from
Homelessness (PATH formula grant)
54
53
60
12.0%
Protection and Advocacy for Individuals with
Mental Illness (PAIMI formula grant)
34 35 34 -2.5%
Subtotal, CMHS budget authority
862
889
763
-14.2%
PHS Evaluation Tap fundinga
21 21 21
0.0%
Subtotal CMHS program level
884
911
784
-13.9%
Center for Substance Abuse Treatment (CSAT)
Programs of Regional and National Significance 395
396
326
-17.7%
PHS Evaluation Tap funding (non-add)a
(4) (4) (11) 160.3%
PRNS, program level (non-add)
(399)
(400)
(337)
-15.8%
Substance Abuse Prevention and Treatment
(SAPT) Block Grant
1,679
1,680
1,699
1.1%
PHS Evaluation Tap funding (non-add)a
(79)
(79)
(79)
0.0%
SAPT Block Grant, program level (non-add)
(1,759)
(1,759)
(1,779)
1.1%
Subtotal, CSAT budget authority
2,074
2,076
2,025
-2.5%
Subtotal, PHS Evaluation Tap fundinga 84 84 90
17.5%
Subtotal, CSAT program level
2,158
2,159
2,115
-2.0%
Center for Substance Abuse Prevention (CSAP)
Programs of Regional and National Significance 193
194
158
-18.6%
Subtotal, CSAP budget authority
193
194
158
-18.6%
Subtotal, Program Management budget
authority 77
75
75
0.0%
PHS Evaluation Tap fundinga 16
18
22
22.5%
Subtotal, Program Management
program level
93
93
97
4.3%
St. Elizabeths Hospital Buildings &
Facilities 0
0
1
na
Data Evaluation
0
0
2
na
Total, SAMHSA budget authority
3,206
3,234
3,025
-6.5%
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
řŚȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
FY2007
FY2008
FY2009 Pres. % change FY09
Centers
actual
enacted
request
vs. FY08
Total, PHS Evaluation Tap fundinga
121 122 133
8.9%
TOTAL, SAMHSA program level
3,327 3,356 3,158 -5.9%
Source: Adapted by CRS from SAMHSA, Justification of Estimates for Appropriations Committees, Fiscal Year
2009, p. Executive Summary-4.
Note: Totals and percentages may not compute exactly due to rounding.
a. Additional funds from PHS Evaluation Set-Aside (§ 241 of PHS Act).
??’?’˜—Š•ȱ˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱǻǼȱ
Ž™˜›?œȱ
Agency Overview Reports CRS Report RL34334, The Food and Drug Administration: Budget
and Statutory History, FY1980-FY2007, coordinated by Judith A. Johnson.
CRS Report RL33022, Indian Health Service: Health Care Delivery, Status, Funding, and
Legislative Issues, by Roger Walke.
CRS Report RL33695, The National Institutes of Health (NIH): Organization, Funding, and
Congressional Issues, by Pamela W. Smith.
CRS Report RL33997, Substance Abuse and Mental Health Services Administration (SAMHSA):
Reauthorization Issues, by Ramya Sundararaman.
Appropriations Reports
CRS Report RL34132, Agriculture and Related Agencies: FY2008 Appropriations, by Jim
Monke.
CRS Report RL34448, Federal Research and Development Funding: FY2009, by John F. Sargent
Jr. et al.
CRS Report RL34461, Interior, Environment, and Related Agencies: FY2009 Appropriations, by
Carol Hardy Vincent et al.
CRS Report RL34076, Labor, Health and Human Services, and Education: FY2008
Appropriations, by Pamela W. Smith, Gerald Mayer, and Rebecca R. Skinner.
’—”œȱ?˜ȱŽ•ŽŒ?Ž?ȱŽ™˜›?œȱ˜—ȱž››Ž—?ȱŽ?’œ•Š?’ŸŽȱ œœžŽœȱ
Biomedical Research Policy and Funding:
http://apps.crs.gov/cli/cli.aspx?PRDS_CLI_ITEM_ID=2257&from=3&fromId=13.
Drugs, Biologics, and Medical Devices:
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
řśȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
http://apps.crs.gov/cli/cli.aspx?PRDS_CLI_ITEM_ID=2678&from=3&fromId=13.
Food Safety and Nutrition:
http://apps.crs.gov/cli/cli.aspx?PRDS_CLI_ITEM_ID=2621&from=3&fromId=13.
Public Health and Emergency Preparedness:
http://apps.crs.gov/cli/cli.aspx?PRDS_CLI_ITEM_ID=2628&from=3&fromId=13.

ž?‘˜›ȱ˜—?ŠŒ?ȱ —?˜›–Š?’˜—ȱ

Pamela W. Smith, Coordinator
Judith A. Johnson
Analyst in Biomedical Policy
Specialist in Biomedical Policy
psmith@crs.loc.gov, 7-7048
jajohnson@crs.loc.gov, 7-7077
Sarah A. Lister
Donna V. Porter
Specialist in Public Health and Epidemiology
Specialist in Nutrition and Food Safety
slister@crs.loc.gov, 7-7320
dporter@crs.loc.gov, 7-7032
Bernice Reyes-Akinbileje
Andrew R. Sommers
Analyst in Health Resources and Services
Analyst in Public Health and Epidemiology
breyes@crs.loc.gov, 7-2260
asommers@crs.loc.gov, 7-4624
Ramya Sundararaman
Susan Thaul
Analyst in Public Health
Specialist in Drug Safety and Effectiveness
rsundararaman@crs.loc.gov, 7-7285
sthaul@crs.loc.gov, 7-0562
Roger Walke

Specialist in American Indian Policy
rwalke@crs.loc.gov, 7-8641

Ž¢ȱ˜•’Œ¢ȱ?Š??ȱ
Area of Expertise
Name
Phone
Public Health Service (PHS) generally
Pamela Smith
7-7048
Sarah Lister
7-7320
Agency for Healthcare Research and Quality
Andrew Sommers
7-4624
(AHRQ)
Centers for Disease Control and Prevention
Sarah Lister
7-7320
(CDC) / Agency for Toxic Substances and Disease
Registry (ATSDR)
Food and Drug Administration (FDA)
Susan Thaul (drugs)
7-0562
Donna Porter (foods)
7-7032
Judith Johnson (biologics)
7-7077
Erin Williams (devices)

Sarah Lister (animal feed and
7-7320
drugs)
˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
řŜȱ

ž‹•’Œȱ ŽŠ•?‘ȱŽ›Ÿ’ŒŽȱǻ Ǽȱ?Ž—Œ’ŽœǱȱŠŒ”?›˜ž—?ȱŠ—?ȱž—?’—?ȱ
ȱ
Area of Expertise
Name
Phone
Health Resources and Services Administration
Bernice Reyes-Akinbileje
7-2260
(HRSA)
Indian Health Service (IHS)
Roger Walke
7-8641
National Institutes of Health (NIH)
Pamela Smith
7-7048
Substance Abuse and Mental Health Services
Ramya Sundararaman
7-7285
Administration (SAMHSA)

˜—?›Žœœ’˜—Š•ȱŽœŽŠ›Œ‘ȱŽ›Ÿ’ŒŽȱ
řŝȱ